Software that turns clinical conversations into medical documentation.
Disclosed investors: Andreessen Horowitz, Khosla Ventures
For clinicians · 4 sources

An AI assistant for clinical documentation and workflows.
A public listing does not imply membership or availability for introductions.
Customers
clinicians
Business model
subscription
Funding
Venture-backed
Revenue: Not disclosed in the reviewed sources.
Clinicians
85,000
clinicians · Clinicians using the product at announcement
2025-06-17 · public disclosure
Amounts describe the announced round, not each investor’s contribution. Individual check sizes are not disclosed here. Historical rounds are not a current ownership list.
2025-06-17 · public disclosure
Series C
$70,000,000 · announced amount
Disclosed participants: HV Capital, Highland Europe, DST Global, Cathay Innovation, Build Collective
Nabla — public disclosure ↗Documented actions and reported outcomes. These are starting points for experiments, not proof that a tactic caused growth.
No sourced growth example added yet. Founder contributions can help fill this in.
Profile reviewed 2026-09-25. Disclosures are historical snapshots unless a live connection is explicitly identified.
Checked 2026-09-24
Checked 2026-09-24
Checked 2026-09-25
Software that turns clinical conversations into medical documentation.
Disclosed investors: Andreessen Horowitz, Khosla Ventures
For clinicians · 4 sources
AI documentation and administrative workflow software for healthcare.
Clinical specialties supported
100+
Product coverage at announcement; not customers or patients
2025-07-29 · Source ↗Disclosed investors: Oak HC/FT, Andreessen Horowitz +8
For clinicians · 2 sources
Healthcare appointment booking and practice software.
Patients in Germany
10,000,000
German patient user base in 2021; not worldwide patients
2022-05-25 · Source ↗Disclosed investors: General Atlantic, Eurazeo +3
For clinicians · 2 sources